Vineet Laboratories Ltd
NSE:VINEETLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Vineet Laboratories Ltd
Other Current Assets
Vineet Laboratories Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Vineet Laboratories Ltd
NSE:VINEETLAB
|
Other Current Assets
₹35.1m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Other Current Assets
₹32B
|
CAGR 3-Years
25%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Other Current Assets
₹12.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
20%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Other Current Assets
₹48.5B
|
CAGR 3-Years
31%
|
CAGR 5-Years
19%
|
CAGR 10-Years
36%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Other Current Assets
₹11.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
13%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Other Current Assets
₹4.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
2%
|
|
Vineet Laboratories Ltd
Glance View
Vineet Laboratories Ltd. specializes in pharmaceutical intermediates and fine chemicals. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2021-06-15. The firm is specialized in manufacturing pharmaceutical intermediates and fine chemicals. The firm is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium, Isopropyl-beta-D-thiogalactopyranoside (IPTG), 4-Nitrophenyl phosphate disodium salt (PNPP), 4-Chlorobutyryl chloride, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, n-Butylnitrite, Ethyldiazo acetate, Phenylboronic acid, Dimethyl phenoxy acetyl chloride and Piroctone Olamine.
See Also
What is Vineet Laboratories Ltd's Other Current Assets?
Other Current Assets
35.1m
INR
Based on the financial report for Mar 31, 2025, Vineet Laboratories Ltd's Other Current Assets amounts to 35.1m INR.
What is Vineet Laboratories Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
54%
Over the last year, the Other Current Assets growth was -48%. The average annual Other Current Assets growth rates for Vineet Laboratories Ltd have been -10% over the past three years , 54% over the past five years .
